MDSC present in the tumour microenvironment have the capacity to suppress the cytotoxic effects of NK cells and the adaptive immune response mediated by CD4+ and CD8+ T cells, strongly inhibiting the anti-tumour effects of these cells [14, 15]. This evidence concerns the gene CD8A and neoplasm.